Millrace Asset Group, Inc. Veracyte, Inc. Transaction History

Millrace Asset Group, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 31, 2022	SELL	$16.58 - $27.9 $451,572 - $759,884	-27,236 Reduced 29.3%	65,735 $1.09 Million
Q2 2022 Jul 28, 2022	BUY	$15.45 - $29.52 $1.44 Million - $2.74 Million	92,971 New	92,971 $1.85 Million
Q1 2021 May 12, 2021	SELL	$44.47 - $81.38 $192,243 - $351,805	-4,323 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$32.49 - $61.88 $222,491 - $423,754	-6,848 Reduced 61.3%	4,323 $212,000
Q3 2020 Nov 17, 2020	SELL	$26.73 - $35.67 $419,233 - $559,448	-15,684 Reduced 58.4%	11,171 $363,000
Q2 2020 Aug 13, 2020	SELL	$19.49 - $28.11 $412,583 - $595,060	-21,169 Reduced 44.08%	26,855 $696,000
Q1 2020 May 13, 2020	SELL	$16.13 - $30.17 $88,973 - $166,417	-5,516 Reduced 10.3%	48,024 $1.17 Million
Q4 2019 Feb 13, 2020	SELL	$20.78 - $29.99 $653,738 - $943,485	-31,460 Reduced 37.01%	53,540 $1.5 Million
Q3 2019 Nov 14, 2019	BUY	$23.87 - $30.93 $286,440 - $371,160	12,000 Added 16.44%	85,000 $2.04 Million
Q2 2019 Aug 13, 2019	SELL	$22.1 - $28.56 $1.33 Million - $1.71 Million	-60,000 Reduced 45.11%	73,000 $2.08 Million
Q1 2019 May 14, 2019	SELL	$12.0 - $25.76 $924,000 - $1.98 Million	-77,000 Reduced 36.67%	133,000 $3.33 Million
Q4 2018 Feb 13, 2019	SELL	$9.15 - $14.85 $640,500 - $1.04 Million	-70,000 Reduced 25.0%	210,000 $2.64 Million
Q3 2018 Nov 13, 2018	BUY	$9.55 - $12.64 $477,500 - $632,000	50,000 Added 21.74%	280,000 $2.67 Million
Q2 2018 Aug 14, 2018	BUY	$5.39 - $9.66 $1.24 Million - $2.22 Million	230,000 New	230,000 $2.15 Million

311

82M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.14B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of Millrace Asset Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Millrace Asset Group, Inc. with notifications on news.